The importance of the auxiliary component Syn3 in bladder cancer therapy should be noted, as it overcame the difficulties of effective adenoviral transduction of urothelial cells, leading to high and sustained concentrations of IFNα in the urine and tumor regression [177]. This evidence concerns the gene IFNA1 and urinary bladder carcinoma.